$ACHV

$6.54 +$0.05 (0.77%) Close

$ACHV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 102.9M shares outstanding

Who owns ACHV?

By type of holder

Institutions 80.2% Insiders 7.6% Everyone else 12.3%

Concentration Top 10 holders own 77.0%

James G. Coulter 13.4% · Jon Winkelried 13.4%

Institutional ownership

80.2%

+59.3 pts vs last qtr

Institutional holders

110

+29 vs last qtr

Net shares bought

+61.0M

by institutions in Q2 2026

New / sold out

48 / 19

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Frazier Life Sciences Management, L.P. NEW +7.6M
TPG GP A, LLC NEW +6.9M

Biggest sellers in Q2 2026

Millennium Management LLC SOLD OUT −1.1M
Nantahala Capital Management, LLC SOLD OUT −648.9K

Who is planning to sell?

Notices of proposed sale, last 12 months

$155K

1 notice from 1 person

Shares covered

20.6K

0.02% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Stewart Richard Alistair Director $155K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+1503.4%

+74.18% a year

Each share's claim on the business

−93.8%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $24.3M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years21% 3–5 years1% 1–3 years14% Under 1 year64%

Quarterly turnover

157.9%

of institutional shares changed hands

Top 10 managers, median time held

3 quarters

Super Investors

Investment managers reporting ACHV on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
FL Frazier Life Sciences Management, L.P.	7.6M	7.40%	NEW	Q2 '26	1.1%
Shares held by quarter Peak holding7.6M (Q2'26) Change over 8 quarters+7.6M Share of the company7.400% Frazier Life Sciences Management, L.P.'s full portfolio →
TG TPG GP A, LLC 13D · 12.6%	6.9M	6.68%	NEW	Q2 '26	0.9%
Shares held by quarter Peak holding6.9M (Q2'26) Change over 8 quarters+6.9M Share of the company6.680% Disclosed stake13D · 12.6% TPG GP A, LLC's full portfolio →

Frazier Life Sciences Management, L.P.

7.6M

% of company

7.40%

Change vs last qtr

NEW

Held since

Q2 '26

TPG GP A, LLC

13D · 12.6%

6.9M

% of company

6.68%

Change vs last qtr

NEW

Held since

Q2 '26

28 more super investors behind a free account

See every manager holding Achieve Life Sciences, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ACHV on Form N-PORT; together they hold 15.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$20.3M	3.1M	3.02%	0.00%	June 30, 2026
EH Eventide Healthcare & Life Sciences Fund Mutual Fund Series Trust	$14.5M	2.2M	2.16%	0.81%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$20.3M

% of company

3.02%

% of the fund

0.00%

As of

June 30, 2026

Eventide Healthcare & Life Sciences Fund

Mutual Fund Series Trust

Position value

$14.5M

% of company

2.16%

% of the fund

0.81%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Achieve Life Sciences, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
JG James G. Coulter 5%+ holder 13D · 12.6%	13.8M	13.37%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.370% Disclosed stake13D · 12.6% View the 13D/G filing →
JW Jon Winkelried 5%+ holder 13D · 12.6%	13.8M	13.37%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company13.370% Disclosed stake13D · 12.6% View the 13D/G filing →

James G. Coulter

5%+ holder13D · 12.6%

13.8M

% of company

13.37%

Change vs last qtr

—

Held since

—

Jon Winkelried

5%+ holder13D · 12.6%

13.8M

% of company

13.37%

Change vs last qtr

—

Held since

—

8 more holders behind a free account

See every insider and 5%+ holder of Achieve Life Sciences, Inc..

Comments